Kodiak Sciences Inc
KOD
NASDAQ
Biotechnology
$41.35
USD
+1.37 (+3.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.53B
Volume 746.9K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-230.66M
TTM
-21.0%
YoY
Operating Cash Flow
$-146.94M
TTM
-37.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 15.4 | 12.8 | 11.9 | 12.0 | 11.2 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 59.1 | 55.5 | 62.4 | 57.5 | 59.8 |
Operating Income | -59.1 | -55.5 | -62.4 | -57.5 | -59.8 |
EBITDA | -54.5 | -50.9 | -57.8 | -52.9 | -55.7 |
Other Income / Expense | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
Total Other Income / Expense | 1.6 | 1.2 | 0.9 | 0.7 | 1.6 |
Income Before Income Taxes | -57.5 | -54.3 | -61.5 | -56.7 | -58.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -57.5 | -54.3 | -61.5 | -56.7 | -58.2 |
Consolidated Net Income / Loss | -57.5 | -54.3 | -61.5 | -56.7 | -58.2 |
Net Income Attributable to Common Shareholders | -57.5 | -54.3 | -61.5 | -56.7 | -58.2 |
Basic EPS | -$1.09 | -$1.03 | -$1.16 | -$1.04 | -$0.94 |
Diluted EPS | -$1.09 | -$1.03 | -$1.16 | -$1.04 | -$0.94 |
Basic Shares Outstanding | 52.7M | 52.8M | 52.9M | 54.4M | 61.9M |
Diluted Shares Outstanding | 52.7M | 52.8M | 52.9M | 54.4M | 61.9M |